Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.
Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan; Department of Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.
J Hepatol. 2018 Jul;69(1):110-120. doi: 10.1016/j.jhep.2018.02.009. Epub 2018 Feb 16.
BACKGROUND & AIMS: Liver repair following hepatic ischemia/reperfusion (I/R) injury is crucial to survival. This study aims to examine the role of endogenous prostaglandin E (PGE) produced by inducible microsomal PGE synthase-1 (mPGES-1), a terminal enzyme of PGE generation, in liver injury and repair following hepatic I/R.
mPGES-1 deficient (Ptges) mice or their wild-type (WT) counterparts were subjected to partial hepatic ischemia followed by reperfusion. The role of E prostanoid receptor 4 (EP4) was then studied using a genetic knockout model and a selective antagonist.
Compared with WT mice, Ptges mice exhibited reductions in alanine aminotransferase (ALT), necrotic area, neutrophil infiltration, chemokines, and proinflammatory cytokine levels. Ptges mice also showed promoted liver repair and increased Ly6C macrophages (Ly6C/CD11b/F4/80-cells) with expression of anti-inflammatory and reparative genes, while WT mice exhibited delayed liver repair and increased Ly6C macrophages (Ly6C/CD11b/F4/80-cells) with expression of proinflammatory genes. Bone marrow (BM)-derived mPGES-1-deficient macrophages facilitated liver repair with increases in Ly6C macrophages. In vitro, mPGES-1 was expressed in macrophages polarized toward the proinflammatory profile. Mice treated with the mPGES-1 inhibitor Compound III displayed increased liver protection and repair. Hepatic I/R enhanced the hepatic expression of PGE receptor subtype, EP4, in WT mice, which was reduced in Ptges mice. A selective EP4 antagonist and genetic deletion of Ptger4, which codes for EP4, accelerated liver repair. The proinflammatory gene expression was upregulated by stimulation of EP4 agonist in WT macrophages but not in EP4-deficient macrophages.
These results indicate that mPGES-1 regulates macrophage polarization as well as liver protection and repair through EP4 signaling during hepatic I/R. Inhibition of mPGES-1 could have therapeutic potential by promoting liver repair after acute liver injury.
Hepatic ischemia/reperfusion injury is a serious complication that occurs in liver surgery. Herein, we demonstrated that inducible prostaglandin E synthase (mPGES-1), an enzyme involved in synthesizing prostaglandin E, worsens the injury and delays liver repair through accumulation of proinflammatory macrophages. Inhibition of mPGES-1 offers a potential therapy for both liver protection and repair in hepatic ischemia/reperfusion injury.
肝缺血/再灌注(I/R)损伤后肝脏的修复对于生存至关重要。本研究旨在探讨诱导型微粒体前列腺素 E 合酶-1(mPGES-1)产生的内源性前列腺素 E(PGE)作为 PGE 生成的终末酶在肝 I/R 后肝损伤和修复中的作用。
将 mPGES-1 缺陷(Ptges)小鼠或其野生型(WT)对照小鼠进行部分肝缺血再灌注。然后使用基因敲除模型和选择性拮抗剂研究 E 前列腺素受体 4(EP4)的作用。
与 WT 小鼠相比,Ptges 小鼠的丙氨酸氨基转移酶(ALT)、坏死面积、中性粒细胞浸润、趋化因子和促炎细胞因子水平降低。Ptges 小鼠还表现出促进的肝脏修复和增加 Ly6C 巨噬细胞(Ly6C/CD11b/F4/80-细胞),这些细胞表达抗炎和修复基因,而 WT 小鼠则表现出延迟的肝脏修复和增加 Ly6C 巨噬细胞(Ly6C/CD11b/F4/80-细胞),这些细胞表达促炎基因。骨髓(BM)来源的 mPGES-1 缺陷型巨噬细胞通过增加 Ly6C 巨噬细胞促进肝脏修复。体外,mPGES-1 在向促炎表型极化的巨噬细胞中表达。用 mPGES-1 抑制剂化合物 III 治疗的小鼠表现出增加的肝脏保护和修复。肝 I/R 增强 WT 小鼠肝内 PGE 受体亚型 EP4 的表达,而 Ptges 小鼠的表达减少。选择性 EP4 拮抗剂和 EP4 编码基因 Ptger4 的基因缺失加速了肝脏修复。在 WT 巨噬细胞中刺激 EP4 激动剂上调促炎基因表达,但在 EP4 缺陷型巨噬细胞中则不然。
这些结果表明,mPGES-1 通过 EP4 信号在肝 I/R 期间调节巨噬细胞极化以及肝脏保护和修复。抑制 mPGES-1 通过促进急性肝损伤后的肝脏修复可能具有治疗潜力。
肝缺血/再灌注损伤是肝外科手术中发生的一种严重并发症。在此,我们证明了参与合成前列腺素 E 的诱导型前列腺素 E 合酶(mPGES-1)通过积累促炎巨噬细胞加重损伤并延迟肝脏修复。抑制 mPGES-1 可为肝缺血/再灌注损伤中的肝脏保护和修复提供一种潜在的治疗方法。